Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06926491 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Final enrollment: 13 participants (planned 6)
    • Site details revised at 9 of 9 sites
    • Eligibility criteria expanded, about 5 words
  2. Site details revised at 8 of 9 sitesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial will evaluate the efficacy of KK8398 on annualized height velocity after 52 weeks of repeated administration of KK8398 to patients with achondroplasia
Trial Details
NCT Number NCT06926491
Lead Sponsor Kyowa Kirin Co., Ltd.
Conditions
(from sponsor)		 Achondroplasia
Related terms Achondroplasia
Enrollment 13 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov